Inclusion Criteria:~* Patients aged 60 to 85 years, inclusive, with a NIA-AA diagnosis of mild cognitive
impairment (MCI) due to AD or early stage mild dementia due to AD. AD diagnosis should be made by an
appropriately qualified medical specialist and AD pathology should be confirmed by either:~ 1. Historical
records of amyloid CSF assessment or~ 2. Historical records of amyloid PET scan or~ 3. If neither historical
records are available, then AD pathological diagnosis confirmation should be offered at screening:~ i. CSF
collection or ii. Amyloid PET iii. Past medical records of MRI or CT are optional.~* Mini Mental State
Examination (MMSE) score between 20-28, inclusive.~* Free Recall score â‰¤17 or Total Recall score <40 on the
Free and Cued Selective Reminding Test (FCSRT).~* Participants are either outpatients, or residents of an
assisted-living facility. Participant has a designated study partner, who spends at least 10hrs per week with
the participant, in order that assessments e.g. carer burden instruments are completed with true knowledge of
the participant.~* No suicidal ideation of type 4 or 5 in the Columbia Suicide Severity Rating Scale (C-SSRS)
in the past 3 months (i.e. active suicidal thought(s) with intent but without specific plan, or active suicidal
thought(s) with plan and intent) OR suicidal behavior in the past 2 years (i.e. actual attempt, interrupted
attempt, aborted attempt, or preparatory acts or behavior).~* Confirmation from the participant that, if of
childbearing potential is not pregnant through urine pregnancy testing.~
